MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Brain PET metabolic substrate of Impulse Control Disorders in Parkinson’s Disease

E. Robin, A. Verger, F. Fluchere, T. Witjas, J.P. Azulay, E. Guedj, A. Eusebio (Marseille, France)

Meeting: 2017 International Congress

Abstract Number: 1518

Keywords: Parkinsonism, Positron emission tomography(PET), Resting brain metabolism

Session Information

Date: Thursday, June 8, 2017

Session Title: Parkinson's Disease: Neuroimaging And Neurophysiology

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: The aim of this study was to describe the cerebral metabolic PET substrate and related connectivity changes in Parkinson’s disease patients with impulse control disorders

Background: Impulse control disorders (ICDs) in Parkinson’s disease (PD) are difficult to diagnose and challenging to manage. Functional studies have shown that these ICDs are linked to overstimulation of the mesocorticolimbic reward system by dopaminergic treatments. However, the exact pathophysiology of ICDs in Parkinson’s disease remains partly unknown. The involvement of a network larger than the mesocorticolimbic system has recently been suggested.

Methods: Eighteen PD patients with ICDs and 18 PD patients without ICDs were evaluated using cerebral 18F-fluorodeoxyglucose positron emission tomography. Using SPM8, SPM-T maps comparisons were performed between groups. Metabolic connectivity of previously identified areas was evaluated by means of an interregional correlation analysis method using correlation coefficients of mean values of the cerebral metabolic rate of glucose consumption extracted at the individual level.

Results: Patients with ICDs had had a relative increased metabolism in the right middle and inferior temporal gyri compared to those without ICD (p<0.005, uncorrected, k>130). The connectivity of this area was increased with the right associative posterior junction and dorsolateral frontal cortex extended to the orbitofrontal region (p<0.005, uncorrected, k>130). We also found a decrease in connectivity with the left caudate and with the right parahippocampal gyrus (p<0.005, uncorrected, k>130).

Conclusions: This study showed that addictive behaviors in Parkinson’s disease are associated with the dysfunction of a vast network largely exceeding the mesocorticolimbic system and including temporal and parietal regions. We hypothesize that the latter are particularly involved in the establishment of a mnemonic component of addiction.

To cite this abstract in AMA style:

E. Robin, A. Verger, F. Fluchere, T. Witjas, J.P. Azulay, E. Guedj, A. Eusebio. Brain PET metabolic substrate of Impulse Control Disorders in Parkinson’s Disease [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/brain-pet-metabolic-substrate-of-impulse-control-disorders-in-parkinsons-disease/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/brain-pet-metabolic-substrate-of-impulse-control-disorders-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley